Abstract:Laponite-based drug delivery systems offer many advantages due to unique ionic and physical properties of Laponite. High ionicity and large surface area of Laponite nanoparticles enable the intercalation and dissolution of biomolecules. In this study, we explored the potential of Laponite as a carrier for FG-4592 to support angiogenesis and a carrier for bone morphogenic protein-2 (BMP-2) to support osteogenesis. Interestingly, we found that Laponite promoted the FG-4592 induced upregulation of vascular endothelial growth factor (VEGF) gene expression of human umbilical cord endothelial cells (HUVECs). Additionally, we observed that Laponite could provide a sustained release of BMP-2 and significantly potentiate the osteogenic effects of BMP-2 on adipose derived mesenchymal stem cells (AMSCs). Overall, current findings on Laponite-drug/protein model system provide a unique way to potentiate the angiogenic activities of FG-4592 on HUVECs and osteogenic effects of BMP-2 on AMSCs for tissue engineering application. Future studies will be directed towards gaining deeper understandings of these effects on a co-culture system of HUVECs and AMSCs.

Laponite nano-silicates potentiate the angiogenic effects of FG-4592 and osteogenic effects of BMP-2